{"id":1001660,"date":"2026-09-09T06:16:50","date_gmt":"2026-09-09T10:16:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/radnet-to-host-free-prostate-cancer-webinar-on-september-19-2026\/"},"modified":"2026-09-09T06:16:50","modified_gmt":"2026-09-09T10:16:50","slug":"radnet-to-host-free-prostate-cancer-webinar-on-september-19-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/radnet-to-host-free-prostate-cancer-webinar-on-september-19-2026\/","title":{"rendered":"RadNet to Host Free Prostate Cancer Webinar on September 19, 2026"},"content":{"rendered":"

\nPublic event brings together a radiologist, urologist and robotic surgeon, and a prostate cancer survivor for an informative conversation and live Q&A about prostate cancer screening, diagnosis and treatment
\n<\/h2>\n
\n

LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 outpatient imaging centers and a premier developer of radiology digital health solutions, today announced it will host a free webinar for patients and the general public on Saturday, September 19, 2026, in support of Prostate Cancer Awareness Month.<\/p>\n

Titled \u201cLet\u2019s Talk About It: Prostate Cancer: Your Questions Answered,\u201d the webinar brings together a radiologist, urologist and robotic surgeon, and a prostate cancer survivor for a candid discussion about prostate cancer risk, screening, diagnosis, treatment and life after cancer. Attendees will also have the opportunity to submit questions during a live question-and-answer session.<\/p>\n

Besides skin cancer, prostate cancer is the most commonly diagnosed cancer among American men. Approximately one in eight men will be diagnosed during his lifetime, and an estimated 333,830 new cases will be diagnosed in the United States in 2026.1<\/sup> Although prostate and breast cancer have similar incidence and mortality rates in the United States, only 37% of men age 50 and older reported having a PSA test in the past year, compared with 80% of women ages 50 to 74 who were up to date with mammography.2<\/sup> Age, family history and certain inherited genetic variants can increase a man\u2019s risk of prostate cancer. For men with a strong family history, including two or more first-degree relatives diagnosed with prostate cancer, the relative risk may be four times higher.3<\/sup><\/p>\n

The September 19th webinar will help patients and families better understand these risks, what may happen following an elevated prostate-specific antigen (PSA) test and how advances in prostate MRI and other imaging technologies are informing diagnosis and treatment planning. The webinar also will explore how prostate MRI can help physicians identify suspicious areas that may require further evaluation and support more targeted biopsy decisions for patients with elevated PSA levels.4<\/sup><\/p>\n

The panelists include:<\/p>\n